Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis

Press/Media

Period7 Jul 2025

Media coverage

1

Media coverage

  • TitleCogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis
    Media name/outletMetro - News Channel Nebraska
    Country/TerritoryUnited States
    Date7/07/25
    URLct.moreover.com/?a=57157582192&p=1gw&v=1&x=mB6RsrSt5b-PTKVEpv8SvA
    PersonsNathan Boggs
View all 1
View less